Why SLTs fail on the PQS/QMS: The leadership gap undermining quality

Published: 3-Jul-2026

Senior leadership teams hold the ultimate responsibility for an effective Pharmaceutical Quality System. Yet across the industry, PQS failures remain one of the most consistent findings in regulatory inspections. Why?

Watch: How Strong Leadership Transforms Regulatory and Operational Challenges

In this concise breakdown, we look at the underlying causes of SLT underperformance on the PQS, including:

• limited understanding of PQS purpose and expectations
• weak engagement in Quality Management Review and oversight
• misalignment between quality and other site functions
• cultural barriers that prevent ownership, accountability and challenge
• quality teams failing to communicate value clearly to non-quality leaders

These issues directly contribute to major and critical deficiencies, hinder continuous improvement and create unnecessary risk for patient safety and site compliance.

If your organisation struggles with PQS engagement or leadership visibility, this video provides a clear starting point for understanding the gap and how to close it.

For more on quality culture, QMM and effective leadership in GMP environments, contact NSF by emailing lifesciences@nsf.org

Relevant companies

You may also like